
ZM223
CAS No. 2031177-48-5
ZM223( ZM-223 )
Catalog No. M26524 CAS No. 2031177-48-5
ZM223 is a potent non-covalent inhibitor of NEDD8 activating enzyme (NAE).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 264 | Get Quote |
![]() ![]() |
5MG | 403 | Get Quote |
![]() ![]() |
10MG | 592 | Get Quote |
![]() ![]() |
25MG | 888 | Get Quote |
![]() ![]() |
50MG | 1242 | Get Quote |
![]() ![]() |
100MG | 1701 | Get Quote |
![]() ![]() |
500MG | 3402 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameZM223
-
NoteResearch use only, not for human use.
-
Brief DescriptionZM223 is a potent non-covalent inhibitor of NEDD8 activating enzyme (NAE).
-
DescriptionZM223 is a potent non-covalent inhibitor of NEDD8 activating enzyme (NAE).(In Vitro):ZM223 (0.1-1 μM) inhibits cell growth with IC50s of 100 and 122 nM in HCT-116 and U-2OS cancer cells, respectively. ZM223 (0.1-1 μM) dose-dependently reduces the level of NEDD8 and accumulation of the UBC12 protein thereby reducing the subsequent NEDD8-UBC12 complex.
-
In VitroZM223 (0.1-1 μM; 4 hours) inhibits both HCT-116 and U-2OS cancer cells with IC50s of 100 and 122 nM, respectively.ZM223 (0.1-1 μM; 4 hours) causes a dose-response decrease in the level of NEDD8 and accumulation of the UBC12 protein, indicating the decrease of the subsequent NEDD8-UBC12 complex.Cell Viability Assay Cell Line:HCT116 colon cancer cells and U-2OS osteosarcoma cells Concentration:0.1 μM, 1 μM Incubation Time:4 hours Result:Inhibited both HCT-116 and U-2OS cancer cells.Western Blot Analysis Cell Line:HCT116 colon cancer cells Concentration:0.1 μM, 1 μM Incubation Time:4 hours Result:Caused a decrease in the level of NEDD8 and an increase in the downstream UBC12 protein.
-
In Vivo——
-
SynonymsZM-223
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2031177-48-5
-
Formula Weight502.53
-
Molecular FormulaC23H17F3N4O2S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (165.82 mM)
-
SMILESNc1ccc(SCC(=O)Nc2ccc3nc(NC(=O)c4ccc(cc4)C(F)(F)F)sc3c2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sargeant P, Farndale RW, Sage SO. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem. 1993 Aug 25;268(24):18151-6.
molnova catalog



related products
-
OXF BD 02
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
-
ZL0590
ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
-
PBRM1-BD2-IN-5
PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, with dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5 respectively, and an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2.